Alkermes

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.

About ALKS

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL.

CEO

Richard F. Pops

CEORichard F. Pops

Employees

2,050

Employees2,050

Headquarters

Dublin, Dublin

HeadquartersDublin, Dublin

Founded

2011

Founded2011

Employees

2,050

Employees2,050

ALKS Key Statistics

Market cap

8.64B

Market cap8.64B

Price-Earnings ratio

57.74

Price-Earnings ratio57.74

Dividend yield

—

Dividend yield—

Average volume

2.52M

Average volume2.52M

High today

$52.00

High today$52.00

Low today

$50.54

Low today$50.54

Open price

$51.07

Open price$51.07

Volume

1.56M

Volume1.56M

52 Week high

$55.67

52 Week high$55.67

52 Week low

$25.17

52 Week low$25.17

Stock Snapshot

With a market cap of 8.64B, Alkermes(ALKS) trades at $51.87. The stock has a price-to-earnings ratio of 57.74.

On 2026-07-13, Alkermes(ALKS) stock moved within a range of $50.54 to $52.00. With shares now at $51.87, the stock is trading +2.6% above its intraday low and -0.3% below the session's peak.

Trading activity shows a volume of 1.56M, compared to an average daily volume of 2.52M.

Over the past 52 weeks, Alkermes(ALKS) stock has traded between a high of $55.67 and a low of $25.17.

ALKS News

Benzinga 8h

What's Going on With Alkermes Stock Monday? - Alkermes - Benzinga

...

TipRanks 12h

Alkermes announces results from planned interim analysis of LTE of alixorexton

Alkermes (ALKS) announced results from a planned interim analysis of the ongoing long-term extension, LTE, study evaluating alixorexton in adults with narcoleps...

Simply Wall St 5d

Is Alkermes Fully Priced As Russell 2000 Index Inclusion Draws Fresh Attention?

Advertisement What Alkermes’ Russell 2000 Dynamic Index Addition Signals for Investors Alkermes (NasdaqGS:ALKS) was added to the Russell 2000 Dynamic Index on...

Analyst ratings

81%

of 16 ratings

Buy

81.3%

Hold

12.5%

Sell

6.3%

More ALKS News

TipRanks 5d

Alkermes Ends Generic VIVITROL Supply Agreement with Amneal

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

People also own

Based on the portfolios of people who own ALKS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.